We are live on ! Find out more
CG

Column Group Portfolio holdings

AUM $88.1M
1-Year Est. Return 148.03%
This Fund
S&P 500
This Quarter Est. Return
+62.16%
1 Year Est. Return
+148.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+23.89%
10 Year Est. Return
–
AUM
$81M
AUM Growth
+$15.2M
Cap. Flow
-$15.2M
Cap. Flow %
-18.79%
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
RAPT
RAPT Therapeutics
RAPT
+$15.2M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ORIC icon
1
Oric Pharmaceuticals
ORIC
$1.44B
$42.5M 52.48%
3,540,777
– –
SRZN icon
2
Surrozen
SRZN
$282M
$19.3M 23.88%
1,499,773
– –
TNYA icon
3
Tenaya Therapeutics
TNYA
$163M
$14.9M 18.35%
9,400,290
– –
RAPT
4
DELISTED
RAPT Therapeutics
RAPT
$4.28M 5.29%
166,075
-1,162,538
-88% -$15.2M
RVMD icon
5
Revolution Medicines
RVMD
$43.7B
$2.15K ﹤0.01%
46
– –

Similar funds

PIS
POM Investment Strategies Raleigh, North Carolina $88.3M AUM 15.23% 1-Year Est. Return
FWM
FSR Wealth Management Elmhurst, Illinois $87.8M AUM 10.63% 1-Year Est. Return
WP
Walleye Partners Madison, Wisconsin $87.7M AUM
SHCM
Stone House Capital Management Bay Harbor Islands, Florida $88.5M AUM 149.16% 1-Year Est. Return
YIM
Yoffe Investment Management Lemoyne, Pennsylvania $87.4M AUM 30.8% 1-Year Est. Return
VPW
Variant Private Wealth Tysons, Virginia $88.9M AUM 25.07% 1-Year Est. Return
LC
Luminist Capital Grand Rapids, Michigan $89M AUM 17.66% 1-Year Est. Return
BI
Bradyco Inc Cambridge, Massachusetts $87.2M AUM 8.85% 1-Year Est. Return

Column Group's Q3 2025 Portfolio in Review

As of Q3 2025, Column Group held 5 positions worth $81M, up 23% from $65.7M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Column Group withdrew a net $15.2M in Q3 2025, reducing 1 holding. Its largest reduction was RAPT Therapeutics, cutting an estimated $15.2M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Column Group's biggest Q3 2025 reduction was RAPT Therapeutics, cutting an estimated $15.2M.
  • Column Group's ten largest holdings make up 100% of its $81M portfolio in Q3 2025.
  • Column Group opened 0 new positions and closed 0 in Q3 2025.
  • Column Group's portfolio value rose 23% quarter-over-quarter to $81M.

Based on Column Group's 13F filing for Q3 2025, filed 14 Nov 2025.